audited financial statements

Virbac reports strong 2025 results with 7.9% organic revenue growth and 16.3% adjusted EBIT margin at constant exchange rates, demonstrating robust operational performance.

Sanofi files 2025 annual financial disclosures with U.S. SEC and French AMF regulators, completing required reporting obligations for the international pharmaceutical company.